Cargando…

Discordance between Fluorescence In Situ Hybridization and Immunohistochemistry Analysis of Anaplastic Lymphoma Kinase Rearrangement in Indian Patients with Non-Small Cell Lung Cancer

Aims  This study aims to evaluate the incidence of anaplastic lymphoma kinase (ALK) mutation in nonsmall cell lung cancer (NSCLC) incorporating fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) methods and to look for any discordance. Methods  We evaluated 101 samples obtained...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Manish, Kumar, Kishore, Singh, Harinder Pal, Nair, Suresh, Patel, Amol, Kumar, Ashok, Soni, Sneha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745737/
https://www.ncbi.nlm.nih.gov/pubmed/33354554
http://dx.doi.org/10.1055/s-0040-1721191
_version_ 1783624663658659840
author Kumar, Manish
Kumar, Kishore
Singh, Harinder Pal
Nair, Suresh
Patel, Amol
Kumar, Ashok
Soni, Sneha
author_facet Kumar, Manish
Kumar, Kishore
Singh, Harinder Pal
Nair, Suresh
Patel, Amol
Kumar, Ashok
Soni, Sneha
author_sort Kumar, Manish
collection PubMed
description Aims  This study aims to evaluate the incidence of anaplastic lymphoma kinase (ALK) mutation in nonsmall cell lung cancer (NSCLC) incorporating fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) methods and to look for any discordance. Methods  We evaluated 101 samples obtained from an enriched cohort of NSCLCs patients from the Army Hospital Research and Referral, New Delhi, India, between November 2016 and November 2018. IHC was performed using the highly-sensitive D5F3 rabbit monoclonal primary antibody. FISH was performed with dual-color, break-apart probe (ZytoLight SPEC) on formalin-fixed, and paraffin-embedded tissue. Discordance between IHC and FISH for ALK rearrangements was evaluated. Pearson correlation coefficient ( r ) was performed to identify any association of ALK presence (by IHC and FISH) with smoking brain metastasis, programmed death-ligand (PD-L1) expression, pleural effusion, and histopathological subtype. Results  A total of 7.92% (8/101) cases tested by IHC and 9.9% (10/101) cases tested by FISH were positive for ALK rearrangement. Of 93 ALK IHC-negative cases, 4 were ALK FISH-positive, whereas of 91 ALK FISH-negative cases, 4 were ALK IHC-positive cases. The correlation analysis demonstrated no or very weak correlation in ALK mutations by IHC or FISH with smoking, brain metastasis, PD-L1 expression, pleural effusion, and histopathological examination, except a weak positive correlation ( r = 0.33) observed between brain metastasis and ALK rearrangement identified by FISH. Conclusions  Our study demonstrated a somewhat similar incidence of ALK FISH-positive cases and ALK IHC-positive cases, though the incidence was numerically higher for ALK-FISH method.
format Online
Article
Text
id pubmed-7745737
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Thieme Medical and Scientific Publishers Pvt. Ltd
record_format MEDLINE/PubMed
spelling pubmed-77457372020-12-21 Discordance between Fluorescence In Situ Hybridization and Immunohistochemistry Analysis of Anaplastic Lymphoma Kinase Rearrangement in Indian Patients with Non-Small Cell Lung Cancer Kumar, Manish Kumar, Kishore Singh, Harinder Pal Nair, Suresh Patel, Amol Kumar, Ashok Soni, Sneha South Asian J Cancer Aims  This study aims to evaluate the incidence of anaplastic lymphoma kinase (ALK) mutation in nonsmall cell lung cancer (NSCLC) incorporating fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) methods and to look for any discordance. Methods  We evaluated 101 samples obtained from an enriched cohort of NSCLCs patients from the Army Hospital Research and Referral, New Delhi, India, between November 2016 and November 2018. IHC was performed using the highly-sensitive D5F3 rabbit monoclonal primary antibody. FISH was performed with dual-color, break-apart probe (ZytoLight SPEC) on formalin-fixed, and paraffin-embedded tissue. Discordance between IHC and FISH for ALK rearrangements was evaluated. Pearson correlation coefficient ( r ) was performed to identify any association of ALK presence (by IHC and FISH) with smoking brain metastasis, programmed death-ligand (PD-L1) expression, pleural effusion, and histopathological subtype. Results  A total of 7.92% (8/101) cases tested by IHC and 9.9% (10/101) cases tested by FISH were positive for ALK rearrangement. Of 93 ALK IHC-negative cases, 4 were ALK FISH-positive, whereas of 91 ALK FISH-negative cases, 4 were ALK IHC-positive cases. The correlation analysis demonstrated no or very weak correlation in ALK mutations by IHC or FISH with smoking, brain metastasis, PD-L1 expression, pleural effusion, and histopathological examination, except a weak positive correlation ( r = 0.33) observed between brain metastasis and ALK rearrangement identified by FISH. Conclusions  Our study demonstrated a somewhat similar incidence of ALK FISH-positive cases and ALK IHC-positive cases, though the incidence was numerically higher for ALK-FISH method. Thieme Medical and Scientific Publishers Pvt. Ltd 2020-06 2020-12-14 /pmc/articles/PMC7745737/ /pubmed/33354554 http://dx.doi.org/10.1055/s-0040-1721191 Text en MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Kumar, Manish
Kumar, Kishore
Singh, Harinder Pal
Nair, Suresh
Patel, Amol
Kumar, Ashok
Soni, Sneha
Discordance between Fluorescence In Situ Hybridization and Immunohistochemistry Analysis of Anaplastic Lymphoma Kinase Rearrangement in Indian Patients with Non-Small Cell Lung Cancer
title Discordance between Fluorescence In Situ Hybridization and Immunohistochemistry Analysis of Anaplastic Lymphoma Kinase Rearrangement in Indian Patients with Non-Small Cell Lung Cancer
title_full Discordance between Fluorescence In Situ Hybridization and Immunohistochemistry Analysis of Anaplastic Lymphoma Kinase Rearrangement in Indian Patients with Non-Small Cell Lung Cancer
title_fullStr Discordance between Fluorescence In Situ Hybridization and Immunohistochemistry Analysis of Anaplastic Lymphoma Kinase Rearrangement in Indian Patients with Non-Small Cell Lung Cancer
title_full_unstemmed Discordance between Fluorescence In Situ Hybridization and Immunohistochemistry Analysis of Anaplastic Lymphoma Kinase Rearrangement in Indian Patients with Non-Small Cell Lung Cancer
title_short Discordance between Fluorescence In Situ Hybridization and Immunohistochemistry Analysis of Anaplastic Lymphoma Kinase Rearrangement in Indian Patients with Non-Small Cell Lung Cancer
title_sort discordance between fluorescence in situ hybridization and immunohistochemistry analysis of anaplastic lymphoma kinase rearrangement in indian patients with non-small cell lung cancer
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745737/
https://www.ncbi.nlm.nih.gov/pubmed/33354554
http://dx.doi.org/10.1055/s-0040-1721191
work_keys_str_mv AT kumarmanish discordancebetweenfluorescenceinsituhybridizationandimmunohistochemistryanalysisofanaplasticlymphomakinaserearrangementinindianpatientswithnonsmallcelllungcancer
AT kumarkishore discordancebetweenfluorescenceinsituhybridizationandimmunohistochemistryanalysisofanaplasticlymphomakinaserearrangementinindianpatientswithnonsmallcelllungcancer
AT singhharinderpal discordancebetweenfluorescenceinsituhybridizationandimmunohistochemistryanalysisofanaplasticlymphomakinaserearrangementinindianpatientswithnonsmallcelllungcancer
AT nairsuresh discordancebetweenfluorescenceinsituhybridizationandimmunohistochemistryanalysisofanaplasticlymphomakinaserearrangementinindianpatientswithnonsmallcelllungcancer
AT patelamol discordancebetweenfluorescenceinsituhybridizationandimmunohistochemistryanalysisofanaplasticlymphomakinaserearrangementinindianpatientswithnonsmallcelllungcancer
AT kumarashok discordancebetweenfluorescenceinsituhybridizationandimmunohistochemistryanalysisofanaplasticlymphomakinaserearrangementinindianpatientswithnonsmallcelllungcancer
AT sonisneha discordancebetweenfluorescenceinsituhybridizationandimmunohistochemistryanalysisofanaplasticlymphomakinaserearrangementinindianpatientswithnonsmallcelllungcancer